Can ultrasound spot early arthritis risk in spinal injury patients?

NCT ID NCT07293949

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study uses ultrasound to measure the thickness of ankle cartilage in people with spinal cord injuries and compares it to healthy individuals. The goal is to see if cartilage damage starts early, which could help prevent osteoarthritis. Researchers will also assess participants' mobility and muscle stiffness. The study is currently recruiting 76 adults aged 18 to 60.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify early cartilage damage in spinal cord injury patients, potentially leading to better prevention of osteoarthritis.

What could go wrong

This is an observational study, not a treatment trial. It only measures cartilage thickness and does not test any intervention, so it cannot directly improve health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES (SCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gaziosmanpasa Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••